{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:13:13Z","timestamp":1790197993308,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":676,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Dept. of Science & Technology","award":["SR\/FT\/LS-77\/2012"],"award-info":[{"award-number":["SR\/FT\/LS-77\/2012"]}]},{"DOI":"10.13039\/501100010803","name":"Dept. of Biotechnology","doi-asserted-by":"crossref","award":["BT\/PR6772\/GBD\/27\/468\/2012"],"award-info":[{"award-number":["BT\/PR6772\/GBD\/27\/468\/2012"]}],"id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ygeno.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T04:31:44Z","timestamp":1489033904000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Altered gene expression in late-onset Alzheimer's disease due to SNPs within 3\u2032UTR microRNA response elements"],"prefix":"10.1016","volume":"109","author":[{"given":"Jyoti","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4311-0720","authenticated-orcid":false,"given":"Bibekanand","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygeno.2017.02.006_bb0005","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0010","first-page":"1","article-title":"Mortality from Alzheimer's disease in the United States: data for 2000 and 2010","author":"Tejada-Vera","year":"2013","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11910-013-0381-0","article-title":"Genome-wide association studies in Alzheimer's disease: a review","volume":"13","author":"Tosto","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2012.08.032","article-title":"Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis","volume":"527","author":"Jin","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2013.10.002","article-title":"NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese","volume":"265","author":"Tan","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2174\/156720512800618062","article-title":"DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease","volume":"9","author":"Coppede","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.gene.2014.03.041","article-title":"Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease","volume":"542","author":"Sheng","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrn3234","article-title":"Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease","volume":"13","author":"Qureshi","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0504","article-title":"The RNA-centred view of the synapse: non-coding RNAs and synaptic plasticity","volume":"369","author":"Smalheiser","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0055","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1128\/MCB.01694-08","article-title":"MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets","volume":"29","author":"Le","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0060","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.semcdb.2010.01.009","article-title":"Dysregulated microRNAs in neurodegenerative disorders","volume":"21","author":"Lau","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/emmm.201201974","article-title":"Alteration of the microRNA network during the progression of Alzheimer's disease","volume":"5","author":"Lau","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0070","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer's disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 2","key":"10.1016\/j.ygeno.2017.02.006_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JAD-2011-110017","article-title":"BACE1 as a potential biomarker for Alzheimer's disease","volume":"24","author":"Decourt","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0080","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1158\/0008-5472.CAN-08-2129","article-title":"A SNP in a let-7 microRNA complementary site in the KRAS 3\u2032 untranslated region increases non-small cell lung cancer risk","volume":"68","author":"Chin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.numecd.2012.02.009","article-title":"The human MTHFR rs4846049 polymorphism increases coronary heart disease risk through modifying miRNA binding","volume":"23","author":"Wu","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0090","doi-asserted-by":"crossref","first-page":"13653","DOI":"10.1073\/pnas.1103360108","article-title":"Functional SNP in the microRNA-367 binding site in the 3\u2032UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1326-6-70","article-title":"Alzheimer-specific variants in the 3\u2032UTR of amyloid precursor protein affect microRNA function","volume":"6","author":"Delay","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/rna.8.4.15584","article-title":"A complex crosstalk between polymorphic microRNA target sites and AD prognosis","volume":"8","author":"Mallick","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-016-0186-x","article-title":"miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease","volume":"8","author":"Delay","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0110","doi-asserted-by":"crossref","first-page":"28387","DOI":"10.1038\/srep28387","article-title":"Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease","volume":"6","author":"Ghanbari","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt435","article-title":"CLIP-based prediction of mammalian microRNA binding sites","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature08170","article-title":"Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps","volume":"460","author":"Chi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymeth.2012.08.006","article-title":"Genome-wide identification of miRNA targets by PAR-CLIP","volume":"58","author":"Hafner","year":"2012","journal-title":"Methods"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0140","doi-asserted-by":"crossref","first-page":"D1308","DOI":"10.1093\/nar\/gkr798","article-title":"SNPedia: a wiki supporting personal genome annotation, interpretation and analysis","volume":"40","author":"Cariaso","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0145","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1111\/j.1742-4658.2010.07801.x","article-title":"Control of transferrin expression by beta-amyloid through the CP2 transcription factor","volume":"277","author":"Jang","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1385\/JMN:23:3:213","article-title":"Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease","volume":"23","author":"Edland","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-2012-120946","article-title":"GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer's disease patients","volume":"33","author":"Kamalainen","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jchemneu.2011.06.007","article-title":"Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease","volume":"42","author":"Blalock","year":"2011","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0170","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/cercor\/bht101","article-title":"Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study","volume":"24","author":"Hokama","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0180","doi-asserted-by":"crossref","first-page":"31315","DOI":"10.1074\/jbc.M805371200","article-title":"An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells","volume":"283","author":"Lukiw","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neulet.2009.04.052","article-title":"Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex","volume":"459","author":"Sethi","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008898","article-title":"Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation","volume":"5","author":"Nunez-Iglesias","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0195","doi-asserted-by":"crossref","first-page":"38951","DOI":"10.1074\/jbc.M110.178848","article-title":"Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease","volume":"285","author":"Cui","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-010-0756-0","article-title":"Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter","volume":"121","author":"Wang","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0205","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0210","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1261\/rna.5248604","article-title":"Fast and effective prediction of microRNA\/target duplexes","volume":"10","author":"Rehmsmeier","year":"2004","journal-title":"RNA"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0220","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2010.06.005","article-title":"Expanding the microRNA targeting code: functional sites with centered pairing","volume":"38","author":"Shin","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0225","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gad.1165404","article-title":"The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3\u2032UTR","volume":"18","author":"Vella","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0235","doi-asserted-by":"crossref","first-page":"W475","DOI":"10.1093\/nar\/gkt291","article-title":"The RNAsnp web server: predicting SNP effects on local RNA secondary structure","volume":"41","author":"Sabarinathan","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0240","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-09-3541","article-title":"Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility","volume":"70","author":"Nicoloso","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0245","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jmg.2004.024596","article-title":"Further evidence for LBP-1c\/CP2\/LSF association in Alzheimer's disease families","volume":"42","author":"Bertram","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0250","doi-asserted-by":"crossref","unstructured":"F. Browne, H. Wang, H. Zheng, A computational framework for the prioritization of disease-gene candidates, BMC Genomics, 16 Suppl 9 (2015) S2.","DOI":"10.1186\/1471-2164-16-S9-S2"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2005.039461","article-title":"CYP19 haplotypes increase risk for Alzheimer's disease","volume":"43","author":"Huang","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/alzrt268","article-title":"Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels","volume":"6","author":"Allen","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0265","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.neurobiolaging.2009.09.004","article-title":"No replication of genetic association between candidate polymorphisms and Alzheimer's disease","volume":"32","author":"Cousin","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0270","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mp.4000852","article-title":"Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease","volume":"6","author":"Russ","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0275","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(03)03032-4","article-title":"Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease","volume":"983","author":"Lovell","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0280","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1471-4159.2004.02608.x","article-title":"Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30bp fragment in the proximal promoter region","volume":"90","author":"Ge","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000052830","article-title":"Cytokine levels and phagocytic activity in patients with Alzheimer's disease","volume":"48","author":"Beloosesky","year":"2002","journal-title":"Gerontology"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001308","article-title":"Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE","volume":"7","author":"Wijsman","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0295","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/CCLM.2002.052","article-title":"Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease","volume":"40","author":"Scacchi","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0300","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/hmg\/ddq221","article-title":"Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals","volume":"19","author":"Corneveaux","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0305","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000322538","article-title":"rs5848 variant of progranulin gene is a risk of Alzheimer's disease in the Taiwanese population","volume":"8","author":"Lee","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0310","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.exger.2006.12.001","article-title":"Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease","volume":"42","author":"Culpan","year":"2007","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0315","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0320","first-page":"433","article-title":"HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice","volume":"2","author":"Giunta","year":"2009","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0325","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1523\/JNEUROSCI.5715-08.2009","article-title":"Induction of Toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology","volume":"29","author":"Scholtzova","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1479-7364-4-1-43","article-title":"Evolutionary divergence and functions of the ADAM and ADAMTS gene families","volume":"4","author":"Brocker","year":"2009","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0335","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/NEN.0000000000000158","article-title":"Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice","volume":"74","author":"Hosokawa","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0340","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.neurobiolaging.2006.06.017","article-title":"Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE","volume":"28","author":"Bjork","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0345","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/WNL.0b013e3181d07654","article-title":"Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease","volume":"74","author":"Zou","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ygeno.2017.02.006_bb0350","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02257671","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type","volume":"5","author":"Tham","year":"1993","journal-title":"J. Neural. Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.ygeno.2017.02.006_bb0355","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0304-3940(03)00567-6","article-title":"The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology","volume":"348","author":"Konishi","year":"2003","journal-title":"Neurosci. Lett."}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754317300125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754317300125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:05:30Z","timestamp":1557313530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754317300125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":71,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0888754317300125"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2017.02.006","relation":{},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered gene expression in late-onset Alzheimer's disease due to SNPs within 3\u2032UTR microRNA response elements","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}